1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Pharma ADMET Testing Market – By Testing Type

1.3.2        North America Pharma ADMET Testing Market – By Technology

1.3.3        North America Pharma ADMET Testing Market – By Application

1.3.4        North America Pharma ADMET Testing Market – By Country

2.           North America Pharma ADMET Testing Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Pharma ADMET Testing Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America – PEST Analysis

4.3         Expert Opinion

5.           Pharma ADMET Testing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Rate of Late-Stage Drug Failure

5.1.2        Increasing Number of Product Approvals and Launches

5.2         Market Restraints

5.2.1        High Cost of ADME Testing Studies

5.3         Market Opportunities

5.3.1        Automation and Advancements in ADME Testing

5.4         Future Trends

5.4.1        The Advent of High-Throughput Screening

5.5         Impact Analysis

6.           Pharma ADMET Testing Market– North America Analysis

6.1         North America Pharma ADMET Testing Market Revenue Forecast and Analysis

7.           North America Pharma ADMET Testing Market– By Testing Type

7.1         Overview

7.2         North America Pharma ADMET Testing Market, By Testing Type 2022 & 2028 (%)

7.3         In Vivo ADMET Testing

7.3.1        Overview

7.3.2        In Vivo ADMET Testing - Revenue and Forecast to 2028 (US$ Million)

7.4         In Vitro ADMET Testing

7.4.1        Overview

7.4.2        In Vitro ADMET Testing - Revenue and Forecast to 2028 (US$ Million)

7.5         In Silico ADMET Testing

7.5.1        Overview

7.5.2        In Silico ADMET Testing - Revenue and Forecast to 2028 (US$ Million)

8.           North America Pharma ADMET Testing Market– By Technology

8.1         Overview

8.2         North America Pharma ADMET Testing Market, By Technology 2022 & 2028 (%)

8.3         Cell Culture

8.3.1        Overview

8.3.2        Cell Culture - Market Revenue and Forecast to 2028 (US$ Million)

8.4         High Throughput

8.4.1        Overview

8.4.2        High Throughput - Market Revenue and Forecast to 2028 (US$ Million)

8.5         Molecular Imaging

8.5.1        Overview

8.5.2        Molecular Imaging - Market Revenue and Forecast to 2028 (US$ Million)

8.6         OMICS Technology

8.6.1        Overview

8.6.2        OMICS Technology - Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Pharma ADMET Testing Market– By Application

9.1         Overview

9.2         North America Pharma ADMET Testing Market, By Application 2022 & 2028 (%)

9.3         Systemic Toxicity

9.3.1        Overview

9.3.2        Systemic Toxicity - Market Revenue and Forecasts to 2028 (US$ Million)

9.4         Renal Toxicity

9.4.1        Overview

9.4.2        Renal Toxicity - Market Revenue and Forecasts to 2028 (US$ Million)

9.5         Hepatotoxicity

9.5.1        Overview

9.5.2        Hepatotoxicity - Market Revenue and Forecasts to 2028 (US$ Million)

9.6         Neurotoxicity

9.6.1        Overview

9.6.2        Neurotoxicity - Market Revenue and Forecasts to 2028 (US$ Million)

9.7         Others

9.7.1        Overview

9.7.2        Others - Revenue and Forecasts to 2028 (US$ Million)

10.        North America Pharma ADMET Testing Market– Country Analysis

10.1      North America: Pharma ADMET Testing Market

10.1.1     Overview

10.1.2     North America: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)

10.1.2.1       US: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       Overview

10.1.2.1.2       US: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3       US: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)

10.1.2.1.4       US: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)

10.1.2.1.5       US: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)

10.1.2.2       Canada: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       Overview

10.1.2.2.2       Canada: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3       Canada: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)

10.1.2.2.4       Canada: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)

10.1.2.2.5       Canada: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)

10.1.2.3       Mexico: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       Overview

10.1.2.3.2       Mexico: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3       Mexico: Pharma ADMET Testing Market, by Testing Type, 2020-2028 (US$ Million)

10.1.2.3.4       Mexico: Pharma ADMET Testing Market, by Technology, 2020-2028 (US$ Million)

10.1.2.3.5       Mexico: Pharma ADMET Testing Market, by Application, 2020-2028 (US$ Million)

11.        North America Pharma ADMET Testing Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      CMIC HOLDINGS Co., LTD

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Charles River Laboratories

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      WuXi AppTec

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Promega Corporation

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Sigma-Aldrich (MERCK KGaA)

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Agilent Technologies, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Biovia (Dassault Systèmes)

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Cyprotex Limited

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Bio-Rad Laboratories, Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   IQVIA Inc.

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Pharma ADMET Testing Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico: Pharma ADMET Testing Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico Pharma ADMET Testing Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico Pharma ADMET Testing Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Organic Developments Done by Companies

Table 12.          Inorganic Developments Done by Companies

Table 13.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Pharma ADMET Testing Market Segmentation

Figure 2.           North America Pharma ADMET Testing Market, By Country

Figure 3.           North America Pharma ADMET Testing Market Overview

Figure 4.           In vivo ADMET Testing Segment Held Largest Share of Testing Type Segment in North America Pharma ADMET Testing Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           North America Pharma ADMET Testing Market Impact Analysis of Driver and Restraints

Figure 9.           North America Pharma ADMET Testing Market– Revenue Forecast and Analysis – 2022 - 2028

Figure 10.        North America Pharma ADMET Testing Market, by Testing Type 2022 & 2028 (%)

Figure 11.        In Vivo ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        In Vitro ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        In Silico ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        North America Pharma ADMET Testing Market, by Technology 2022 & 2028 (%)

Figure 15.        Cell Culture - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        High Throughput - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Molecular Imaging - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        OMICS Technology - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        North America Pharma ADMET Testing Market, by Application 2022 & 2028 (%)

Figure 20.        Systemic Toxicity - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Renal Toxicity - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Hepatotoxicity - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Neurotoxicity - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Others - Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        North America: Pharma ADMET Testing Market, by Key Country – Revenue (2022) (US$ Million)

Figure 26.        North America: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)

Figure 27.        US: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Canada: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Mexico: Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)